A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose level was in the target range for a greater percentage of time with a closed-loop system than with a sensor-augmented insulin pump.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-08, Vol.383 (9), p.836-845
Hauptverfasser: Breton, Marc D, Kanapka, Lauren G, Beck, Roy W, Ekhlaspour, Laya, Forlenza, Gregory P, Cengiz, Eda, Schoelwer, Melissa, Ruedy, Katrina J, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Oliveri, Mary, Kollman, Craig C, Dokken, Betsy B, Weinzimer, Stuart A, DeBoer, Mark D, Buckingham, Bruce A, Cherñavvsky, Daniel, Wadwa, R. Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 845
container_issue 9
container_start_page 836
container_title The New England journal of medicine
container_volume 383
creator Breton, Marc D
Kanapka, Lauren G
Beck, Roy W
Ekhlaspour, Laya
Forlenza, Gregory P
Cengiz, Eda
Schoelwer, Melissa
Ruedy, Katrina J
Jost, Emily
Carria, Lori
Emory, Emma
Hsu, Liana J
Oliveri, Mary
Kollman, Craig C
Dokken, Betsy B
Weinzimer, Stuart A
DeBoer, Mark D
Buckingham, Bruce A
Cherñavvsky, Daniel
Wadwa, R. Paul
description A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose level was in the target range for a greater percentage of time with a closed-loop system than with a sensor-augmented insulin pump.
doi_str_mv 10.1056/NEJMoa2004736
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7920146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2437437777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-345e1d7443260b2c13f1326ae651a463628fa8a3704e9daccdd0dd72c49cc20f3</originalsourceid><addsrcrecordid>eNp1kd1LwzAUxYMoOqePvkpAfPChmq-m64sw6seUqSDzOWRJajPaZiadon-9kc2hgpdAQvK7J_dwADjA6BSjlJ_dX97eOUkQYhnlG6CHU0oTxhDfBD2EyCBhWU53wG4IMxQLs3wb7FAyYBxx0gO3Q_goW-0a-2E0nHgra-hKWNQuGJ2MnZvDwrWddzW0LSwqW2tvWvhmuwpO3ucGYnhh5dR0JuyBrVLWweyv9j54urqcFKNk_HB9UwzHiYqjdAllqcE6Y4wSjqZEYVrieJSGp1gyTjkZlHIgaYaYybVUSmukdUYUy5UiqKR9cL7UnS-mjdHKxPFkLebeNtK_Cyet-P3S2ko8u1eR5ST651HgZClQ_WkbDcfi6w5RygjL2SuO7NHqM-9eFiZ0YuYWvo3-BGE0iytWpJIlpbwLwZtyLYuR-IpJ_Iop8oc_Lazp71wicLwEmiaI1syaf4Q-AeIPlx8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2437437777</pqid></control><display><type>article</type><title>A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Breton, Marc D ; Kanapka, Lauren G ; Beck, Roy W ; Ekhlaspour, Laya ; Forlenza, Gregory P ; Cengiz, Eda ; Schoelwer, Melissa ; Ruedy, Katrina J ; Jost, Emily ; Carria, Lori ; Emory, Emma ; Hsu, Liana J ; Oliveri, Mary ; Kollman, Craig C ; Dokken, Betsy B ; Weinzimer, Stuart A ; DeBoer, Mark D ; Buckingham, Bruce A ; Cherñavvsky, Daniel ; Wadwa, R. Paul</creator><creatorcontrib>Breton, Marc D ; Kanapka, Lauren G ; Beck, Roy W ; Ekhlaspour, Laya ; Forlenza, Gregory P ; Cengiz, Eda ; Schoelwer, Melissa ; Ruedy, Katrina J ; Jost, Emily ; Carria, Lori ; Emory, Emma ; Hsu, Liana J ; Oliveri, Mary ; Kollman, Craig C ; Dokken, Betsy B ; Weinzimer, Stuart A ; DeBoer, Mark D ; Buckingham, Bruce A ; Cherñavvsky, Daniel ; Wadwa, R. Paul ; iDCL Trial Research Group</creatorcontrib><description>A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose level was in the target range for a greater percentage of time with a closed-loop system than with a sensor-augmented insulin pump.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa2004736</identifier><identifier>PMID: 32846062</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adolescent ; Age ; Automation ; Blood Glucose ; Blood Glucose - analysis ; Child ; Children ; Closed loop systems ; Diabetes ; Diabetes mellitus (insulin dependent) ; Diabetes Mellitus, Type 1 ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetic Ketoacidosis ; Diabetic Ketoacidosis - etiology ; FDA approval ; Female ; Glucose ; Glycated Hemoglobin A ; Glycated Hemoglobin A - analysis ; Hemoglobin ; Human health and pathology ; Humans ; Hypoglycemia ; Hypoglycemia - chemically induced ; Hypoglycemic Agents ; Hypoglycemic Agents - administration &amp; dosage ; Hypoglycemic Agents - adverse effects ; Infusion Pumps, Implantable ; Injections, Subcutaneous ; Insulin ; Insulin - administration &amp; dosage ; Insulin - adverse effects ; Insulin Infusion Systems ; Insulin Infusion Systems - adverse effects ; Ketoacidosis ; Kidney diseases ; Laboratories ; Life Sciences ; Male ; Pancreas ; Pancreas, Artificial ; Patients ; Quality of life ; Statistical analysis</subject><ispartof>The New England journal of medicine, 2020-08, Vol.383 (9), p.836-845</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2020 Massachusetts Medical Society.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-345e1d7443260b2c13f1326ae651a463628fa8a3704e9daccdd0dd72c49cc20f3</citedby><cites>FETCH-LOGICAL-c479t-345e1d7443260b2c13f1326ae651a463628fa8a3704e9daccdd0dd72c49cc20f3</cites><orcidid>0000-0002-4139-2122 ; 0000-0002-3407-7263</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2004736$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa2004736$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>230,314,776,780,881,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32846062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-03342494$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Breton, Marc D</creatorcontrib><creatorcontrib>Kanapka, Lauren G</creatorcontrib><creatorcontrib>Beck, Roy W</creatorcontrib><creatorcontrib>Ekhlaspour, Laya</creatorcontrib><creatorcontrib>Forlenza, Gregory P</creatorcontrib><creatorcontrib>Cengiz, Eda</creatorcontrib><creatorcontrib>Schoelwer, Melissa</creatorcontrib><creatorcontrib>Ruedy, Katrina J</creatorcontrib><creatorcontrib>Jost, Emily</creatorcontrib><creatorcontrib>Carria, Lori</creatorcontrib><creatorcontrib>Emory, Emma</creatorcontrib><creatorcontrib>Hsu, Liana J</creatorcontrib><creatorcontrib>Oliveri, Mary</creatorcontrib><creatorcontrib>Kollman, Craig C</creatorcontrib><creatorcontrib>Dokken, Betsy B</creatorcontrib><creatorcontrib>Weinzimer, Stuart A</creatorcontrib><creatorcontrib>DeBoer, Mark D</creatorcontrib><creatorcontrib>Buckingham, Bruce A</creatorcontrib><creatorcontrib>Cherñavvsky, Daniel</creatorcontrib><creatorcontrib>Wadwa, R. Paul</creatorcontrib><creatorcontrib>iDCL Trial Research Group</creatorcontrib><title>A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose level was in the target range for a greater percentage of time with a closed-loop system than with a sensor-augmented insulin pump.</description><subject>Adolescent</subject><subject>Age</subject><subject>Automation</subject><subject>Blood Glucose</subject><subject>Blood Glucose - analysis</subject><subject>Child</subject><subject>Children</subject><subject>Closed loop systems</subject><subject>Diabetes</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes Mellitus, Type 1</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetic Ketoacidosis</subject><subject>Diabetic Ketoacidosis - etiology</subject><subject>FDA approval</subject><subject>Female</subject><subject>Glucose</subject><subject>Glycated Hemoglobin A</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Hemoglobin</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Hypoglycemia - chemically induced</subject><subject>Hypoglycemic Agents</subject><subject>Hypoglycemic Agents - administration &amp; dosage</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Infusion Pumps, Implantable</subject><subject>Injections, Subcutaneous</subject><subject>Insulin</subject><subject>Insulin - administration &amp; dosage</subject><subject>Insulin - adverse effects</subject><subject>Insulin Infusion Systems</subject><subject>Insulin Infusion Systems - adverse effects</subject><subject>Ketoacidosis</subject><subject>Kidney diseases</subject><subject>Laboratories</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Pancreas</subject><subject>Pancreas, Artificial</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Statistical analysis</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kd1LwzAUxYMoOqePvkpAfPChmq-m64sw6seUqSDzOWRJajPaZiadon-9kc2hgpdAQvK7J_dwADjA6BSjlJ_dX97eOUkQYhnlG6CHU0oTxhDfBD2EyCBhWU53wG4IMxQLs3wb7FAyYBxx0gO3Q_goW-0a-2E0nHgra-hKWNQuGJ2MnZvDwrWddzW0LSwqW2tvWvhmuwpO3ucGYnhh5dR0JuyBrVLWweyv9j54urqcFKNk_HB9UwzHiYqjdAllqcE6Y4wSjqZEYVrieJSGp1gyTjkZlHIgaYaYybVUSmukdUYUy5UiqKR9cL7UnS-mjdHKxPFkLebeNtK_Cyet-P3S2ko8u1eR5ST651HgZClQ_WkbDcfi6w5RygjL2SuO7NHqM-9eFiZ0YuYWvo3-BGE0iytWpJIlpbwLwZtyLYuR-IpJ_Iop8oc_Lazp71wicLwEmiaI1syaf4Q-AeIPlx8</recordid><startdate>20200827</startdate><enddate>20200827</enddate><creator>Breton, Marc D</creator><creator>Kanapka, Lauren G</creator><creator>Beck, Roy W</creator><creator>Ekhlaspour, Laya</creator><creator>Forlenza, Gregory P</creator><creator>Cengiz, Eda</creator><creator>Schoelwer, Melissa</creator><creator>Ruedy, Katrina J</creator><creator>Jost, Emily</creator><creator>Carria, Lori</creator><creator>Emory, Emma</creator><creator>Hsu, Liana J</creator><creator>Oliveri, Mary</creator><creator>Kollman, Craig C</creator><creator>Dokken, Betsy B</creator><creator>Weinzimer, Stuart A</creator><creator>DeBoer, Mark D</creator><creator>Buckingham, Bruce A</creator><creator>Cherñavvsky, Daniel</creator><creator>Wadwa, R. Paul</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4139-2122</orcidid><orcidid>https://orcid.org/0000-0002-3407-7263</orcidid></search><sort><creationdate>20200827</creationdate><title>A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes</title><author>Breton, Marc D ; Kanapka, Lauren G ; Beck, Roy W ; Ekhlaspour, Laya ; Forlenza, Gregory P ; Cengiz, Eda ; Schoelwer, Melissa ; Ruedy, Katrina J ; Jost, Emily ; Carria, Lori ; Emory, Emma ; Hsu, Liana J ; Oliveri, Mary ; Kollman, Craig C ; Dokken, Betsy B ; Weinzimer, Stuart A ; DeBoer, Mark D ; Buckingham, Bruce A ; Cherñavvsky, Daniel ; Wadwa, R. Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-345e1d7443260b2c13f1326ae651a463628fa8a3704e9daccdd0dd72c49cc20f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Age</topic><topic>Automation</topic><topic>Blood Glucose</topic><topic>Blood Glucose - analysis</topic><topic>Child</topic><topic>Children</topic><topic>Closed loop systems</topic><topic>Diabetes</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes Mellitus, Type 1</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetic Ketoacidosis</topic><topic>Diabetic Ketoacidosis - etiology</topic><topic>FDA approval</topic><topic>Female</topic><topic>Glucose</topic><topic>Glycated Hemoglobin A</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Hemoglobin</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Hypoglycemia - chemically induced</topic><topic>Hypoglycemic Agents</topic><topic>Hypoglycemic Agents - administration &amp; dosage</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Infusion Pumps, Implantable</topic><topic>Injections, Subcutaneous</topic><topic>Insulin</topic><topic>Insulin - administration &amp; dosage</topic><topic>Insulin - adverse effects</topic><topic>Insulin Infusion Systems</topic><topic>Insulin Infusion Systems - adverse effects</topic><topic>Ketoacidosis</topic><topic>Kidney diseases</topic><topic>Laboratories</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Pancreas</topic><topic>Pancreas, Artificial</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Breton, Marc D</creatorcontrib><creatorcontrib>Kanapka, Lauren G</creatorcontrib><creatorcontrib>Beck, Roy W</creatorcontrib><creatorcontrib>Ekhlaspour, Laya</creatorcontrib><creatorcontrib>Forlenza, Gregory P</creatorcontrib><creatorcontrib>Cengiz, Eda</creatorcontrib><creatorcontrib>Schoelwer, Melissa</creatorcontrib><creatorcontrib>Ruedy, Katrina J</creatorcontrib><creatorcontrib>Jost, Emily</creatorcontrib><creatorcontrib>Carria, Lori</creatorcontrib><creatorcontrib>Emory, Emma</creatorcontrib><creatorcontrib>Hsu, Liana J</creatorcontrib><creatorcontrib>Oliveri, Mary</creatorcontrib><creatorcontrib>Kollman, Craig C</creatorcontrib><creatorcontrib>Dokken, Betsy B</creatorcontrib><creatorcontrib>Weinzimer, Stuart A</creatorcontrib><creatorcontrib>DeBoer, Mark D</creatorcontrib><creatorcontrib>Buckingham, Bruce A</creatorcontrib><creatorcontrib>Cherñavvsky, Daniel</creatorcontrib><creatorcontrib>Wadwa, R. Paul</creatorcontrib><creatorcontrib>iDCL Trial Research Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Breton, Marc D</au><au>Kanapka, Lauren G</au><au>Beck, Roy W</au><au>Ekhlaspour, Laya</au><au>Forlenza, Gregory P</au><au>Cengiz, Eda</au><au>Schoelwer, Melissa</au><au>Ruedy, Katrina J</au><au>Jost, Emily</au><au>Carria, Lori</au><au>Emory, Emma</au><au>Hsu, Liana J</au><au>Oliveri, Mary</au><au>Kollman, Craig C</au><au>Dokken, Betsy B</au><au>Weinzimer, Stuart A</au><au>DeBoer, Mark D</au><au>Buckingham, Bruce A</au><au>Cherñavvsky, Daniel</au><au>Wadwa, R. Paul</au><aucorp>iDCL Trial Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2020-08-27</date><risdate>2020</risdate><volume>383</volume><issue>9</issue><spage>836</spage><epage>845</epage><pages>836-845</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose level was in the target range for a greater percentage of time with a closed-loop system than with a sensor-augmented insulin pump.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>32846062</pmid><doi>10.1056/NEJMoa2004736</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4139-2122</orcidid><orcidid>https://orcid.org/0000-0002-3407-7263</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2020-08, Vol.383 (9), p.836-845
issn 0028-4793
1533-4406
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7920146
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects Adolescent
Age
Automation
Blood Glucose
Blood Glucose - analysis
Child
Children
Closed loop systems
Diabetes
Diabetes mellitus (insulin dependent)
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 1 - drug therapy
Diabetic Ketoacidosis
Diabetic Ketoacidosis - etiology
FDA approval
Female
Glucose
Glycated Hemoglobin A
Glycated Hemoglobin A - analysis
Hemoglobin
Human health and pathology
Humans
Hypoglycemia
Hypoglycemia - chemically induced
Hypoglycemic Agents
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - adverse effects
Infusion Pumps, Implantable
Injections, Subcutaneous
Insulin
Insulin - administration & dosage
Insulin - adverse effects
Insulin Infusion Systems
Insulin Infusion Systems - adverse effects
Ketoacidosis
Kidney diseases
Laboratories
Life Sciences
Male
Pancreas
Pancreas, Artificial
Patients
Quality of life
Statistical analysis
title A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A01%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Randomized%20Trial%20of%20Closed-Loop%20Control%20in%20Children%20with%20Type%201%20Diabetes&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Breton,%20Marc%20D&rft.aucorp=iDCL%20Trial%20Research%20Group&rft.date=2020-08-27&rft.volume=383&rft.issue=9&rft.spage=836&rft.epage=845&rft.pages=836-845&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa2004736&rft_dat=%3Cproquest_pubme%3E2437437777%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2437437777&rft_id=info:pmid/32846062&rfr_iscdi=true